KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.95

Effects of preoperative magnetic resonance image on survival rates and surgical planning in breast cancer conservative surgery: randomized controlled trial (BREAST-MRI trial).

Bruna Salani Mota, Yedda Nunes Reis, Nestor de Barros, Natália Pereira Cardoso, Rosa Maria Salani Mota, Carlos Shimizu, Tatiana Cardoso de Mello Tucunduva, Vera Christina Camargo de Siqueira Ferreira, Rodrigo Goncalves, Maíra Teixeira Doria, Marcos Desidério Ricci, Angela Francisca Trinconi, Cristina Pires Camargo, Rachel Riera, Edmund Chada Baracat, José Maria Soares, José Roberto Filassi

Breast Cancer Res Treat 198(3) 447-461

PMID36786946
PMCIDPMC10036439
DOI10.1007/s10549-023-06884-5
发表日期2023-02-14
入排依据:The trial is a Phase III randomized controlled trial in human breast cancer with time-to-event endpoints (LRFS, OS). However, it does not meet the 'drug-containing intervention' requirement as the intervention is preoperative MRI, not a drug. Therefore, it is ineligible.
摘要

摘要

BACKGROUND: Breast magnetic resonance imaging (MRI) has high sensitivity in detecting invasive neoplasms. Controversy remains about its impact on the preoperative staging of breast cancer surgery. This study evaluated survival and surgical outcomes of preoperative MRI in conservative breast cancer surgery. METHODS: A phase III, randomized, open-label, single-center trial including female breast cancer participants, stage 0-III disease, and eligible for breast-conserving surgery. We compared the role of including MRI in preoperative evaluation versus radiologic exam routine with mammography and ultrasound in breast cancer conservative candidates. The primary outcome was local relapse-free survival (LRFS), and secondary outcomes were overall survival (OS), mastectomy rate, and reoperation rate. RESULTS: 524 were randomized to preoperative MRI group (n = 257) or control group (n = 267). The survival analysis showed a 5.9-years LRFS of 99.2% in MRI group versus 98.9% in control group (HR = 0.72; 95% CI 0.12-4.28; p = 0.7) and an OS of 95.3% in the MRI group versus 96.3% in the control group (HR = 1.37 95% CI 0.59-3.19; p = 0.8). Surgical management changed in 21 ipsilateral breasts in the MRI group; 21 (8.3%) had mastectomies versus one in the control group. No difference was found in reoperation rates, 22 (8.7%) in the MRI group versus 23 (8.7%) in the control group (RR = 1.002; 95% CI 0.57-1.75; p = 0.85). CONCLUSION: Preoperative MRI increased the mastectomy rates by 8%. The use of preoperative MRI did not influence local relapse-free survival, overall survival, or reoperation rates.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。